论文部分内容阅读
特拉匹韦(telaprevir,VX-950)是由美国Vertex制药公司开发的用于治疗丙型肝炎的新药,于2011年5月23日获美国FDA批准上市,其商品名为Incivek。该药为口
Telaprevir (VX-950), a new drug developed by Vertex Pharmaceuticals of the United States for the treatment of Hepatitis C, was approved by the U.S. FDA on May 23, 2011 under the trade name Incivek. The drug is the mouth